Evidence map›Paper›PMID 22350617›Full record

ArticleJournal of inherited metabolic disease2012

The cognitive profile of type 1 Gaucher disease patients.

Marieke Biegstraaten, Keith A Wesnes, Cécile Luzy, Milan Petakov, Mirando Mrsic, Claus Niederau, Pilar Giraldo, Derralynn Hughes, Atul Mehta, Karl-Eugen Mengel and 3 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Journal of inherited metabolic disease, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Observational
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 7 countries.

Marieke BiegstraatenDepartment of Internal Medicine, Academic Medical Center, F5-169, Box 22700, 1100 DE, Amsterdam, The Netherlands. m.biegstraaten@amc.uva.nl
Keith A Wesnes
Cécile Luzy
Milan Petakov
Mirando Mrsic
Claus Niederau
Pilar Giraldo
Derralynn Hughes
Atul Mehta
Karl-Eugen Mengel
Carla E M Hollak
László Maródi
Ivo N van Schaik
Academic Medical Center · NLActelion (Switzerland) · CHCentre for Biomedical Network Research on Rare Diseases · ESThe Royal Free Hospital · GBUnited BioSource Corporation (United Kingdom) · GBUniversity College London · GBUniversity Hospital Centre Zagreb · HRUniversity of Debrecen · HUUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe absence of neurological symptoms and signs is traditionally considered mandatory for a diagnosis of type 1 Gaucher disease (GD1), but in recent years many reports have emerged on neurological manifestations in GD1 patients. Nevertheless, it has been unclear whether cognitive deficits are part of the disease as well.

methodsCognitive function was assessed in a large cohort of GD1 patients with the use of the CDR system, a set of computerised cognitive tests. Testing was performed at baseline and every 6 months thereafter during a two-year study period.

resultsOur patient cohort (84 patients, median age 40 years, median time from diagnosis 15 years) showed mild deficits relative to healthy age-matched subjects on the composite scores: power of attention (Z-score (mean ± SD) -0.9 ± 1.37) and speed of memory (Z-score (mean ± SD) -1.39 ± 1.49). No decline in cognitive function was seen during the two-year period. Age correlated with the composite scores variability of attention and quality of working memory. Moreover, severely affected patients (Zimran severity score (SSI) ≥ 15) scored more poorly compared to mildly affected patients (SSI ≤ 5) on the composite measure power of attention, reflecting the ability to concentrate.

conclusionsGD1 patients exhibit mild deficits in power of attention and speed of memory, reflecting a decreased ability to focus attention and process information, together with a slowing in the speed of retrieval of items from memory. The clinical relevance of these findings is uncertain.

Indexed as

CognitionAdolescentAdultAgedAttentionCase-Control StudiesCognition DisordersCohort StudiesEuropeFemaleGaucher DiseaseHumansLongitudinal StudiesMaleMemoryMemory, Short-Term

Identifiers

PMID22350617
PMCPMC3470680
OpenAlexW2062083309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.